Skip to main content
logo
Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
25.22
+1.60 (6.77%)
Sep 21, 2026, 11:55 AM EDT - Market open

Amphastar Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
1,0738908891,2311,2391,0821,3811,7852,3621,9562,1122,9632,2472,7741,7961,3541,3771,6991,7281,114913
Market Cap Growth (YoY)
-14.48%-17.79%-35.66%-31.07%-47.55%-44.67%-34.59%-39.75%5.13%-29.49%17.58%118.80%63.13%63.31%3.91%21.52%50.84%76.90%98.91%16.65%2.55%
Enterprise Value
1,4711,2841,2621,6111,6631,4981,8102,1652,7652,2942,4793,3362,6122,6831,7231,2731,2981,6171,6961,106907
Last Close Price
23.6220.1819.5926.7826.6522.9628.9937.1348.5340.0043.9161.8545.9957.4737.5028.0228.1034.7935.9023.2919.01

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
14.9711.3311.2212.5511.108.049.7511.1914.9811.7513.6521.5416.6127.2119.2814.8217.8318.6921.2517.9425.31
Forward PE
7.947.075.917.787.977.279.189.4212.0410.8912.0920.7717.6023.1418.7516.2915.2719.3322.1616.9617.83
PS Ratio
1.401.221.231.711.711.501.892.443.272.743.124.603.745.133.462.712.843.563.802.552.21
PB Ratio
1.311.161.151.561.601.431.842.443.252.743.144.633.784.713.272.562.733.403.612.502.12
P/TBV Ratio
8.507.404.165.526.066.058.2812.6017.7817.3932.35113.42--3.512.762.943.683.922.742.34
P/FCF Ratio
6.695.826.5810.1510.949.659.2010.3613.8810.9813.1220.3916.0727.6234.9320.7915.3424.1317.2915.8020.50
P/OCF Ratio
5.544.825.267.888.146.787.158.3711.359.2010.6416.1512.8521.1922.7915.1912.0417.5913.7311.3712.27
PEG Ratio
-3.551.407.0130.835.332.820.990.850.800.990.921.071.070.990.860.801.021.170.890.94

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
1.951.761.752.242.302.072.482.963.823.223.675.184.354.963.322.552.683.393.732.532.20
EV/EBITDA Ratio
7.316.606.407.327.276.337.298.3810.378.079.6814.1912.1417.1111.709.6310.8313.4015.9311.6512.21
EV/EBIT Ratio
10.349.359.039.859.618.259.3010.5412.919.8611.7216.9314.2320.4214.1211.8513.5616.6320.4415.4317.86
EV/FCF Ratio
9.308.409.3413.2914.6813.3512.0512.5616.2512.8815.4022.9518.6826.7233.5019.5514.4522.9716.9715.6820.38

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.900.900.890.830.850.870.870.890.870.870.930.981.130.900.190.190.200.210.220.240.25
Debt / EBITDA Ratio
3.333.333.292.852.782.672.552.462.312.142.402.593.053.270.670.750.830.830.951.051.33
Debt / FCF Ratio
4.504.505.085.415.805.844.343.783.703.483.904.294.815.261.981.581.151.481.051.482.38
Net Debt / Equity Ratio
0.520.520.510.470.490.560.550.590.520.560.500.570.630.62-0.17-0.14-0.16-0.16-0.17-0.07-0.02
Net Debt / EBITDA Ratio
2.052.052.001.701.661.791.671.661.421.421.321.561.732.33-0.62-0.55-0.67-0.66-0.77-0.34-0.11
Net Debt / FCF Ratio
2.602.602.923.083.363.782.772.492.232.262.102.522.673.64-1.77-1.12-0.90-1.13-0.82-0.45-0.19
Asset Turnover
0.440.440.440.450.450.470.460.470.470.500.580.570.530.520.700.710.700.690.670.670.65
Inventory Turnover
2.062.062.132.202.322.312.402.762.832.822.822.802.562.602.512.552.472.552.542.512.22
Quick Ratio
1.661.662.732.802.072.141.922.072.492.551.681.651.631.072.792.792.672.612.282.081.97
Current Ratio
2.402.403.854.023.123.292.953.073.433.522.172.172.111.533.863.993.763.643.193.063.10
Return on Equity (ROE)
10.30%10.30%10.39%12.90%14.84%18.32%19.90%23.26%23.85%25.57%25.34%23.55%24.59%18.73%18.12%18.76%16.51%19.10%17.97%14.16%8.57%
Return on Assets (ROA)
5.11%5.11%5.34%6.37%6.73%7.31%7.60%8.31%8.67%10.13%11.26%10.92%10.10%7.81%10.24%9.51%8.68%8.75%7.62%6.88%5.02%
Return on Invested Capital (ROIC)
9.06%9.06%9.25%11.19%12.18%12.88%13.71%15.27%16.34%18.07%17.65%16.21%15.22%14.71%20.87%19.44%17.41%18.96%15.96%12.95%9.11%
Return on Capital Employed (ROCE)
9.30%9.30%9.40%11.10%11.80%12.60%13.60%14.60%15.50%17.20%16.00%15.30%14.30%11.70%18.30%16.60%15.30%15.70%13.80%12.60%9.20%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
7.68%8.83%8.91%7.97%9.01%12.45%10.25%8.94%6.68%8.51%7.32%4.64%6.02%3.67%5.19%6.75%5.61%5.35%4.71%5.57%3.95%
FCF Yield
14.94%17.18%15.21%9.85%9.14%10.37%10.88%9.65%7.20%9.11%7.62%4.91%6.22%3.62%2.86%4.81%6.52%4.14%5.78%6.33%4.88%
Buyback Yield / Dilution
7.79%7.79%7.65%7.38%6.16%5.10%3.73%1.78%0.36%-1.15%-1.60%-1.09%-1.27%-2.10%-4.02%-5.31%-4.65%-3.33%-1.94%-1.34%-1.43%
SEC Filings: 10-K · 10-Q